PFCS

Pale Fire Capital SE Portfolio holdings

AUM $912M
1-Year Est. Return 102.69%
This Quarter Est. Return
1 Year Est. Return
+102.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$912M
AUM Growth
-$46M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$33.7M
2
+$32.4M
3
+$12.9M
4
KURA icon
Kura Oncology
KURA
+$5.2M
5
NUVB icon
Nuvation Bio
NUVB
+$4.99M

Top Sells

1
+$77.9M
2
+$44.6M
3
+$18.4M
4
SPPP
Sprott Physical Platinum and Palladium Trust
SPPP
+$13.8M
5
MTCH icon
Match Group
MTCH
+$12.9M

Sector Composition

1 Materials 44.35%
2 Communication Services 30.53%
3 Consumer Staples 12.72%
4 Healthcare 10.95%
5 Energy 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM icon
26
Journey Medical
DERM
$221M
$1.63M 0.18%
228,567
+196,109
CMRC
27
Commerce.com Inc Series 1
CMRC
$369M
$1.49M 0.16%
+298,631
CYBN
28
Cybin
CYBN
$287M
$904K 0.1%
153,505
+40,700
AGRO icon
29
Adecoagro
AGRO
$833M
$664K 0.07%
84,637
XFOR icon
30
X4 Pharmaceuticals
XFOR
$318M
$619K 0.07%
180,851
+120,800
HRTX icon
31
Heron Therapeutics
HRTX
$244M
$594K 0.07%
+471,190
QDEL icon
32
QuidelOrtho
QDEL
$1.86B
$536K 0.06%
+18,209
AQST icon
33
Aquestive Therapeutics
AQST
$744M
$521K 0.06%
93,132
-1,583,319
LFCR icon
34
Lifecore Biomedical
LFCR
$284M
$476K 0.05%
64,620
+33,934
PESI icon
35
Perma-Fix Environmental Services
PESI
$266M
$457K 0.05%
45,270
+19,581
TARS icon
36
Tarsus Pharmaceuticals
TARS
$3.38B
$420K 0.05%
+7,075
ETNB
37
DELISTED
89bio
ETNB
$395K 0.04%
26,903
+325
RZLT icon
38
Rezolute
RZLT
$913M
$394K 0.04%
41,922
-7,200
HROW icon
39
Harrow
HROW
$1.79B
$390K 0.04%
8,093
-590
ARWR icon
40
Arrowhead Research
ARWR
$9.35B
$349K 0.04%
10,123
-3,448
IMTX icon
41
Immatics
IMTX
$1.35B
$292K 0.03%
34,270
LXEO icon
42
Lexeo Therapeutics
LXEO
$694M
$223K 0.02%
33,650
+6,000
MITT
43
AG Mortgage Investment Trust
MITT
$262M
$222K 0.02%
30,728
-20,474
MUX icon
44
McEwen Inc
MUX
$1.05B
$217K 0.02%
12,695
+345
BHVN icon
45
Biohaven
BHVN
$1.39B
$155K 0.02%
+10,344
LRMR icon
46
Larimar Therapeutics
LRMR
$345M
$146K 0.02%
45,218
+7,700
AKBA icon
47
Akebia Therapeutics
AKBA
$419M
$137K 0.02%
+50,210
VZLA
48
Vizsla Silver
VZLA
$1.79B
$133K 0.01%
30,728
-8,072
ENGN icon
49
enGene Holdings
ENGN
$550M
$118K 0.01%
17,254
CGEM icon
50
Cullinan Oncology
CGEM
$730M
$86.7K 0.01%
+14,615
1
2
3